BENSALEM, Pa.--(BUSINESS WIRE)--
announces that it is investigating potential claims on behalf of investors of Applied DNA Sciences Inc. (“Applied DNA Sciences” or the “Company”) (Nasdaq: ) concerning the Company’s and its officers’ possible violations of federal securities laws.
published a alleging that the Company “has spent 6.6x more on insider compensation than R&D” and “is now facing...